Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the International AIDS Society"
DOI: 10.1002/jia2.25747
Abstract: Vaginal rings are a promising approach to provide a woman‐centred, long‐acting HIV prevention strategy. Prior trials of a 25 mg dapivirine (DPV) ring have shown a favourable safety profile and approximately 30% risk reduction of… read more here.
Keywords: vaginal rings; phase pharmacokinetics; safety; pharmacokinetics safety ... See more keywords